Position in AMGN
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$73,148
+$2,778 QoQ
Shares Held
202
+1.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.65%
of 13F equity value
Holder Rank
#2,971
of 3,140 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Evolution Advisers, Inc. holds $209,630 across 10 Drug Manufacturers - General names. AMGN ranks #2 (34.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
509 | $129,270 | |
| 2 | AMGN |
Amgen Inc
This page
|
202 | $73,148 | |
| 3 | LLY |
ELI LILLY & Co
|
3 | $3,598 | |
| 4 | ABBV |
AbbVie Inc.
|
5 | $1,258 | |
| 5 | MRK |
Merck & Co., Inc.
|
5 | $642 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
4 | $505 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
8 | $460 | |
| 8 | OGN |
Organon & Co.
|
27 | $365 |
All Filings in AMGN
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $73,148 | 202 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $70,370 | 200 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $65,462 | 200 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $56,440 | 200 | Shares | Sole | 2026-01-23 | |
| 2025-06-30 | $55,842 | 200 | Shares | Sole | 2025-07-25 | |
| 2025-03-31 | $62,310 | 200 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $52,128 | 200 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $64,442 | 200 | Shares | Sole | 2024-10-18 | |
| 2024-06-30 | $62,490 | 200 | Shares | Sole | 2024-07-26 | |
| 2024-03-31 | $56,864 | 200 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $57,604 | 200 | Shares | Sole | 2024-02-02 | |
| No filing history on record for this holder in this stock. | ||||||